SEC Comment Letter for PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081) (PTCT) — Oct 27, 2021

PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081)
Date: Oct. 27, 2021 · CIK: 0001070081 · Accession: 0000000000-21-013030

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-35969

Date

October 27, 2021

Author

Emily Hill

Form

UPLOAD

Company

PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081)

Letter

United States securities and exchange commission logo October 27, 2021 Emily Hill Chief Financial Officer PTC Therapeutics, Inc. 100 Corporate Court South Plainfield, NJ 07080 Re:PTC Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2020 Filed February 25, 2021 File No. 001-35969 Dear Ms. Hill: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
October 27, 2021
Emily Hill
Chief Financial Officer
PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield, NJ 07080
Re:PTC Therapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2020
Filed February 25, 2021
File No. 001-35969
Dear Ms. Hill:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io